Oncology Clinical Trials in Brooklyn, NY
As of June 2026, 47 paid clinical trials are recruiting for Oncology in Brooklyn, New York. Oncology trials evaluate immunotherapies, targeted therapies, antibody-drug conjugates, and combination regimens across solid tumors and blood cancers — from early-phase first-in-human studies to phase 3 registration trials. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
47 clinical trials for Oncology
·Clear filters·↓ Download CSVEmapalumab Prophylaxis of Bispecific T-Cell Engagers (BiTEs) Associated CRS and ICANS
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
SafeHeal Colovac Anastomosis Protection Device Evaluation Pivotal Study
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
Pilot Trial of Spiritual Care Interventions for Patients With Cancer
Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain
A First-in-Human Study of MEN2312 in Adults With Advanced Breast Cancer
A Culturally-Tailored Mobile Health and Social Media Physical Activity Intervention for Improving Physical Activity in Hispanic or Latino/Latina Adolescent and Young Adult Childhood Cancer Survivors, Walking Juntos Study
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Saruparib (AZD5305) Plus Camizestrant Compared With CDK4/6 Inhibitor Plus Endocrine Therapy or Plus Camizestrant in HR-Positive, HER2-Negative (IHC 0, 1+, 2+/ ISH Non-amplified), BRCA1, BRCA2, or PALB2m Advanced Breast Cancer
Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib
Clinical Outcomes in Prostate Cancer Patients Undergoing HIFU Ablation
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
Clinical Trial Evaluating Low Dose G-FLIP Plus Mitomycin C for Stage IV Pancreatic Cancer
Proactive Outreach With FIT
Mobile Health for Adherence in Breast Cancer Patients
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Transgenerational Metabolic-Immune Biomarkers of Neurological and Neurodevelopmental Disorders
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
A Study to Compare Iberdomide Maintenance Versus Lenalidomide Maintenance Therapy Following Autologous Stem Cell Transplant in Participants With Newly Diagnosed Multiple Myeloma
The Radiation Oncology-Biology Integration Network (ROBIN) Molecular Characterization Trial (MCT) of Standard Short Course Radiotherapy for Rectal Cancer
Chatbot to Maximize Hereditary Cancer Genetic Risk Assessment
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer
Developing New Educational Materials About Genetic Testing for a Diverse Group of Cancer Patients
Phase I/II Trial of Pembrolizumab and Androgen-receptor Inhibitor With or Without 225Ac-J591 for Progressive Metastatic Castration Resistant Prostate Cancer
Phase I Study of 225Ac-J591 Plus 177Lu-PSMA Small Molecule for Progressive Metastatic Castration Resistant Prostate Cancer
ATEMPT 2.0: Adjuvant T-DM1 vs TH
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
Personalized Second Chance Breast Conservation (PSCBC): A Prospective Phase II Clinical Study
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
About research studies in Brooklyn
Brooklyn has approximately 208 recruiting research studies across a wide range of therapeutic areas. New York is home to leading academic medical centers such as Memorial Sloan Kettering, Weill Cornell Medicine, Mount Sinai, NYU Langone, and Columbia University Irving Medical Center. These institutions anchor a research ecosystem that covers oncology, cardiology, neurology, and rare disease.
Top Research Study Locations in Brooklyn
Researchers run research studies in Brooklyn, NY at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Maimonides Medical Center | Acute Myeloid Leukemia, Malignant Solid Neoplasm, Mixed Phenotype Acute Leukemia | 40 |
| NYU Langone Hospital - Brooklyn | Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8 | 13 |
| New York-Presbyterian/Brooklyn Methodist Hospital | Breast Cancer, Stage IV Renal Cell Cancer AJCC v8, Advanced Esophageal Adenocarcinoma | 12 |
| NewYork-Presbyterian Brooklyn Methodist Hospital | Coronary Artery Disease, Heart Diseases, Advanced Breast Cancer | 9 |
| Ellipsis Research Group | Gout, Ulcerative Colitis, Moderately to Severely Active Crohns Disease | 7 |
| Brooklyn Clinical Research | Cardiovascular Diseases, Diabetes Type 2, Diabetic Peripheral Neuropathic Pain | 5 |
| New York Presbyterian Brooklyn Methodist Hospital | Advanced Cancer, Breast Cancer, Cerebrovascular Accident | 5 |
| Integrative Clinical Trials LLC | Depressive Disorder, Major, Bipolar Depression, Bipolar Disorder | 4 |
| NYU Langone Health | Anxiety, Clostridioides Difficile Associated Disease, Colorectal Cancer | 4 |
| Integrative Clinical Trials | Agitation Associated With Alzheimer's Disease Dementia, Major Depressive Disorder, Bipolar I or II Disorder | 4 |
| NYU Langone Brooklyn | Chronic Cutaneous Lupus Erythematosus, Sedative During Endoscopy, Subacute Cutaneous Lupus Erythematosus | 3 |
| Integrative Clinical Trials, LLC | Aggression, Agitation,Psychomotor, Alzheimer Disease | 3 |
| Clindove Research | Diabetes Mellitus, Type 2, Heart Failure, Metabolic Syndrome | 2 |
| Clindove Research LLC | Cardiovascular Diseases, Chronic Kidney Disease (CKD), Endocrine Dysfunction | 2 |
| Integrative Clinical Trials, Merz Investigational | Chronic Migraine, Episodic Migraine | 2 |
| Kings County Hopsital Center | Breast Cancer, Colorectal Cancer, Educational Materials for Genetic Testing | 2 |
| Kings County Hospital Center | Atrial Fibrillation, Breast Cancer, Intracerebral Hemorrhage | 2 |
| Maimonides Cancer Center | Carcinoma, Non-Small-Cell Lung, DCIS, Ductal Breast Carcinoma In Situ | 2 |
| NYC Health+Hospitals | Sickle Cell Disease, Thalassemia | 2 |
| NYU Langone Hospital | Coronary Arterial Disease (CAD), Ischemic Stroke, de Novo Lesions in Native Coronary Arteries | 2 |
| North Shore Hematology Oncology Associates P.C. DBA New York Cancer and Blood Specialists | Carcinoma, Non-Small Cell Lung, Colonic Diseases, Colorectal Neoplasms | 2 |
| SUNY Downstate Health Sciences University | Diabetes Mellitus, Diabetes Mellitus Progression, Endocrine System Diseases | 2 |
| Seaport Investigator Site | Major Depressive Disorder (MDD), Major Depressive Disorder With Anxious Distress | 2 |
| State University of New York, Downstate | Autism Spectrum Disorder, Brain Tumor, Epilepsy | 2 |
| AABP | Lumbar Spinal Stenosis | 1 |
Active & Upcoming Studies in Brooklyn (2026)
Recruiting trials in Brooklyn grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (66 active studies)
- Decision Support Tool for Patients With Advanced Breast Cancer · Weill Medical College of Cornell University
- Emapalumab Prophylaxis of Bispecific T-Cell Engagers (BiTEs) Associated CRS and ICANS · Phase 2 · NYU Langone Health
Neurology & pain (19 active studies)
- Minocycline in Stroke Study at Maimonides · Phase 2, Phase 3 · Joyce Chen
- Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy · Phase 3 · Vertex Pharmaceuticals Incorporated
Cardiovascular (17 active studies)
- A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity · Phase 3 · Novo Nordisk A/S
- AGENT DCB STANCE: Safety and Effectiveness Study of AGENT Drug-Coated Balloon Compared to Standard of Care Percutaneous Coronary Intervention (PCI) Treatment for de Novo Coronary Lesions · Boston Scientific Corporation
Mental health & behavior (11 active studies)
- Implementation of a Clinical Decision Support Tool for Postpartum Depression · Weill Medical College of Cornell University
- A Study of NTX-1472 in Social Anxiety Disorder · Phase 2 · Newleos Therapeutics, Inc.
Diabetes & metabolic (8 active studies)
- A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity · Phase 3 · Novo Nordisk A/S
- Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight · Phase 3 · Eli Lilly and Company
Vaccines (4 active studies)
- A Study to Evaluate the Safety and Efficacy of CD388 for Prevention of Influenza · Phase 3 · Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
- Randomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSistent NEurologic and Cardiopulmonary Symptoms of Long COVID · Phase 3 · Wes Ely
HIV / STI (1 active study)
- Triage Survey for Infectious Disease Eligibility · Brooklyn Clinical Research
Pediatric (1 active study)
- In-Person Lifestyle Program for Black Adolescent Girls at Risk for Type 2 Diabetes · Cornell University
Common conditions studied in Brooklyn
- Breast Cancer (6 active studies). Breast cancer trials evaluate new hormone therapies, targeted drugs, and immunotherapy combinations aimed at improving survival and reducing recurrence.
- Prostate Cancer (5 active studies). Prostate cancer studies test next-generation hormone therapies, PARP inhibitors, and radioligand treatments for both localized and advanced disease.
- Anatomic Stage II Breast Cancer AJCC v8 (4 active studies). Breast cancer trials evaluate new hormone therapies, targeted drugs, and immunotherapy combinations aimed at improving survival and reducing recurrence.
- Cardiovascular Diseases (4 active studies). Recruiting Cardiovascular Diseases studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Heart Failure (4 active studies). Heart failure trials explore SGLT-2 inhibitors, novel myosin modulators, and device-based therapies for both reduced and preserved ejection fraction.
- Major Depressive Disorder (4 active studies). Major depressive disorder research examines rapid-acting agents, augmentation strategies, and digital therapeutics for treatment-resistant cases.
Leading research sponsors in Brooklyn
- Weill Medical College of Cornell University
- AstraZeneca
- Children's Oncology Group
- NRG Oncology
- NYU Langone Health
Local regulations and guidelines
Clinical trials in New York are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. Trials conducted in New York must also comply with the NY SHIELD Act's data-protection requirements and additional oversight from the New York State Department of Health.
Compensation & what to expect
- How payment typically works
- Compensation is most often provided through reloadable electronic study cards or direct deposit, paid out per completed visit rather than as a lump sum. Amounts vary by the time required, the number of visits, and the study's complexity — overnight stays and inpatient pharmacology studies generally pay more than short outpatient surveys. The exact amount is disclosed in writing during informed consent before any visit.
- Healthy volunteers
- Healthy participants aged 18 and older can earn compensation by joining vaccine, pharmacology, and biomarker studies in Brooklyn. These trials check how a new drug or vaccine behaves in healthy bodies before later-phase testing. Many sites maintain a healthy-volunteer registry so you hear about new opportunities first.
- What's included beyond payment
- Most trials cover study-related medical care at no cost — physical exams, lab work, imaging, the investigational treatment itself, and follow-up visits with the research team. Insurance is not required to participate. Free check-ups and access to specialists are common reasons participants return for additional studies.
- Travel and time
- Many sponsors reimburse travel, parking, mileage, and lost wages for visit days. Long-running studies and trials that require frequent visits often raise stipends accordingly. Ask the study coordinator for the visit schedule and reimbursement policy before you commit.
- Asking about compensation
- Compensation is set per protocol and per site, so figures are not published in trial registries. The fastest way to confirm payment for a specific study is to contact the recruiting site listed on the study record. Coordinators are accustomed to this question and will quote the per-visit and total amounts up front.
How to find a clinical trial in Brooklyn
Hipa.ai aggregates every recruiting study in Brooklyn from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
Frequently asked questions
How many paid clinical trials are currently recruiting in Brooklyn?
There are approximately 208 recruiting clinical trials in Brooklyn, New York listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Brooklyn pay participants?
Most recruiting trials in Brooklyn compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Brooklyn?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Brooklyn?
The most common conditions under active study in Brooklyn include Breast Cancer (6), Prostate Cancer (5), Anatomic Stage II Breast Cancer AJCC v8 (4), Cardiovascular Diseases (4), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Brooklyn?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Brooklyn on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Brooklyn?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Brooklyn?
Recruiting research sites in Brooklyn include Maimonides Medical Center, NYU Langone Hospital - Brooklyn, New York-Presbyterian/Brooklyn Methodist Hospital, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Brooklyn right now?
The largest active categories in Brooklyn are Cancer & tumors (66), Neurology & pain (19), Cardiovascular (17). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.